|
Re: Thoughts?
|
8
|
Resverlogix Corp.
|
Apr 06, 2021 02:03AM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
8
|
Resverlogix Corp.
|
Jun 02, 2022 01:26PM
|
|
Re: Is something bigger than a US listing being worked on?
|
8
|
Resverlogix Corp.
|
Aug 07, 2018 12:46PM
|
|
Re: "We have the vaccine, but we shouldn’t be resting on our laurels...."
|
8
|
Resverlogix Corp.
|
Jul 21, 2021 06:17PM
|
|
Re: AGM attendance
|
8
|
Resverlogix Corp.
|
May 24, 2022 04:30PM
|
|
There is hope for us
|
8
|
Zenith Epigenetics
|
Jan 08, 2018 05:10PM
|
|
Re: COVID 19 & BP
|
8
|
Resverlogix Corp.
|
Jun 27, 2020 01:37PM
|
|
Re: BETonMACE Placebo Estimate
|
8
|
Resverlogix Corp.
|
Feb 20, 2019 03:15PM
|
|
Re: Right of first refusal
|
8
|
Resverlogix Corp.
|
Mar 03, 2019 10:48AM
|
|
Re: US to shell out $1.2B for supplies of Merck's potential Covid-19 antiviral.
|
8
|
Resverlogix Corp.
|
Jun 10, 2021 01:02PM
|
|
Re: Coronary Artery Calcium Score
|
8
|
Resverlogix Corp.
|
Feb 18, 2019 06:14PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
8
|
Resverlogix Corp.
|
Aug 15, 2017 03:58PM
|
|
Re: Can't you feel the excitment?
|
8
|
Resverlogix Corp.
|
Aug 16, 2019 02:34AM
|
|
Seems to be some interest
|
8
|
Resverlogix Corp.
|
Apr 11, 2022 10:17AM
|
|
Re: Breakthrough Therapy Question....response from IR
|
8
|
Resverlogix Corp.
|
Jan 06, 2020 10:46PM
|
|
3 cheers for Don and the RVX team
|
8
|
Resverlogix Corp.
|
Feb 03, 2020 07:00PM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
8
|
Resverlogix Corp.
|
Jul 07, 2020 11:28AM
|
|
Re: Prospects for resverlogix
|
8
|
Resverlogix Corp.
|
Jul 15, 2020 12:21PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
8
|
Resverlogix Corp.
|
Jun 22, 2017 03:12PM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
8
|
Resverlogix Corp.
|
Oct 12, 2019 03:10PM
|
